Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage

NCT07131696 is registered in ClinicalTrials.gov with Marshall Holland as lead sponsor.

NCT NCT07131696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07131696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
Lead sponsor
Marshall Holland
Phase
Not applicable
Overall status
Recruiting
Start date
February 6, 2026
Completion date
September 30, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage, endovascular treatment, transcutaneous vagal nerve stimulation (tvns), vasospasm, cerebral